Free Cash Flow Chart

View Free Cash Flow for ELAN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 379.00M
March 31, 2026 315.00M
December 31, 2025 284.00M
September 30, 2025 362.00M
June 30, 2025 347.00M
March 31, 2025 333.00M
December 31, 2024 380.00M
September 30, 2024 372.00M
June 30, 2024 425.00M
March 31, 2024 278.00M
December 31, 2023 117.00M
September 30, 2023 -65.00M
June 30, 2023 -87.00M
March 31, 2023 173.00M
December 31, 2022 268.00M
September 30, 2022 466.00M
Date Value
June 30, 2022 387.00M
March 31, 2022 232.00M
December 31, 2021 286.00M
September 30, 2021 -85.80M
June 30, 2021 -349.70M
March 31, 2021 -342.20M
December 31, 2020 -348.30M
September 30, 2020 -93.60M
June 30, 2020 111.70M
March 31, 2020 9.00M
December 31, 2019 26.70M
September 30, 2019 91.10M
June 30, 2019 231.80M
March 31, 2019 316.10M
December 31, 2018 352.80M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Zoetis, Inc. 2.366B
Eli Lilly & Co. 13.56B
ANI Pharmaceuticals, Inc. 167.52M
EyePoint, Inc. -271.28M
Amylyx Pharmaceuticals, Inc. -130.72M